Tumor-specific P73 Up-regulation Mediates P63 Dependence in Squamous Cell Carcinoma.
From: Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
Cancer research
- Publish Date: Oct 2006
- ISSN: 1538-7445
- Volume: 66
- Issue: 19
- Pages: 9362-8
- Medium: Internet
- Language: English
- Citation (JAMA): DeYoung Maurice Phillip, Johannessen Cory M, Leong Chee-Onn, et al. Tumor-specific P73 Up-regulation Mediates P63 Dependence in Squamous Cell Carcinoma.. Cancer Res. Oct 2006;66:9362-8
Abstract
p63 is essential for normal epithelial development and is overexpressed in the vast majority of squamous cell carcinomas (SCC). Recent work had shown that DeltaNp63alpha is essential for survival of SCC cells, raising the possibility that the p63 pathway may be an attractive therapeutic target in these tumors. Nevertheless, it is unknown whether a therapeutic window exists for inhibiting p63 in tumor cells versus normal epithelia. Here, we show that SCC cells are uniquely dependent on DeltaNp63alpha for survival, unlike normal p63-expressing epithelial cells, and that dependence is mediated through tumor-specific up-regulation of the related protein p73. In normal primary human keratinocytes, we find that inhibition of endogenous p63 by RNA interference (RNAi) induces p21(CIP1) expression, inhibits cell cycle progression, and ultimately promotes cellular senescence. In contrast, p63 inhibition in SCC cells induces proapoptotic bcl-2 family members and rapidly triggers apoptosis. Expression of p73 is low in uncultured basal keratinocytes but is markedly up-regulated in both SCC cell lines and primary tumors in vivo. Whereas p21(CIP1) induction following loss of p63 in normal cells is independent of p53 and p73, both proapoptotic gene induction and cell death following p63 RNAi in tumor cells are p73 dependent. Finally, ectopic p73 expression in primary keratinocytes does not affect baseline cell proliferation but is sufficient to trigger cell death following loss of p63. Together, these findings define a specific molecular mechanism of p63 dependence through p73 up-regulation, and they provide a rationale for targeting the p63 pathway as a therapeutic strategy in SCCs.
Mesh Headings (Keywords): Animals, Carcinoma, Squamous Cell, Cell Cycle, Cells, Cultured, Cyclin-Dependent Kinase Inhibitor p21, DNA-Binding Proteins, Humans, Keratinocytes, Mice, Mice, Knockout, Neoplasm Proteins, Nuclear Proteins, Phosphoproteins, RNA, Small Interfering, Skin Neoplasms, Trans-Activators, Transduction, Genetic, Tumor Suppressor Protein p53, Tumor Suppressor Proteins
Check for Full Text / PubMed Unique Identifier (PMID): 17018588
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.